Gubra A/S (CPH:GUBRA)
357.20
-3.60 (-1.00%)
Sep 7, 2026, 9:43 AM CET
Gubra Revenue
Gubra had revenue of 126.35M DKK in the half year ending June 30, 2026, with 4.74% growth. This brings the company's revenue in the last twelve months to 271.02M, down -89.72% year-over-year. In the year 2025, Gubra had annual revenue of 2.64B with 892.25% growth.
Revenue (ttm)
271.02M
Revenue Growth
-89.72%
P/S Ratio
21.86
Revenue / Employee
821.28K
Employees
330
Market Cap
5.93B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.64B | 2.37B | 892.25% |
| Dec 31, 2024 | 265.74M | 60.74M | 29.63% |
| Dec 31, 2023 | 205.01M | 5.62M | 2.82% |
| Dec 31, 2022 | 199.38M | -55.95M | -21.91% |
| Dec 31, 2021 | 255.33M | 83.03M | 48.19% |
| Dec 31, 2020 | 172.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 329.43B |
| Coloplast | 28.44B |
| Genmab | 27.03B |
| H. Lundbeck | 25.96B |
| Demant | 24.63B |
| GN Store Nord | 16.46B |
| Embla Medical | 6.44B |
| Bavarian Nordic | 6.34B |
Gubra News
- 13 days ago - Gubra Slides: Investor presentation - Filings
- 13 days ago - Gubra Quarterly report: Q2 2026 - Filings
- 13 days ago - Gubra Slides: Q2 2026 - Filings
- 17 days ago - Gubra Earnings Call Transcript: Q2 2026 - Transcripts
- 17 days ago - Gubra Quarterly report: Q2 2026 - Filings
- 17 days ago - Gubra Slides: Q2 2026 - Filings
- 2 months ago - Gubra Slides: Investor presentation - Filings
- 3 months ago - Gubra Earnings release: Q1 2026 - Filings